SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001477932-19-007303
Filing Date
2019-12-26
Accepted
2019-12-26 17:18:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 ipix_424b3.htm 424B3 38749
  Complete submission text file 0001477932-19-007303.txt   39929
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-220419 | Film No.: 191311114
SIC: 2834 Pharmaceutical Preparations